ShoreHaven Wealth Partners’s AXS Cannabis ETF THCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,372
Closed -$29.5K 76
2023
Q1
$29.5K Sell
1,372
-2
-0.1% -$50 0.02% 70
2022
Q4
$35.6K Sell
1,374
-202
-13% -$6.02K 0.03% 75
2022
Q3
$43K Sell
1,576
-736
-32% -$27K 0.03% 67
2022
Q2
$85K Buy
2,312
+229
+11% +$12K 0.06% 69
2022
Q1
$157K Sell
2,083
-148
-7% -$11K 0.08% 62
2021
Q4
$190K Buy
2,231
+101
+5% +$11.1K 0.09% 50
2021
Q3
$273K Buy
2,130
+173
+9% +$25.4K 0.14% 38
2021
Q2
$335K Buy
1,957
+392
+25% +$68.6K 0.18% 39
2021
Q1
$308K Buy
1,565
+373
+31% +$73.1K 0.17% 42
2020
Q4
$149K Buy
+1,192
New +$132K 0.08% 59

Other funds holding THCX

ShoreHaven Wealth Partners's THCX Position: Q2 2023 in Review

ShoreHaven Wealth Partners sold out of AXS Cannabis ETF (THCX) in Q2 2023, closing a stake of 1,372 shares — an estimated $29.5K sold.

ShoreHaven Wealth Partners first reported a position in THCX in Q4 2020 and held it in 10 quarters. The position peaked at $335K in Q2 2021. 27 funds tracked by Wall St. Rank hold THCX as of Q2 2023.

  • ShoreHaven Wealth Partners reported no remaining AXS Cannabis ETF position as of Q2 2023 after selling out during the quarter.
  • ShoreHaven Wealth Partners sold 1,372 AXS Cannabis ETF shares in Q2 2023, an estimated $29.5K.
  • ShoreHaven Wealth Partners first reported a position in AXS Cannabis ETF in Q4 2020 and held it in 10 quarters.
  • ShoreHaven Wealth Partners's AXS Cannabis ETF position peaked at $335K in Q2 2021.
  • 27 funds tracked by Wall St. Rank held AXS Cannabis ETF as of Q2 2023.

Based on ShoreHaven Wealth Partners's 13F filing for Q2 2023, filed 19 Jul 2023.